Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endotoxin Activity Assay as a Prognostic Factor in Gram-negative Septic Shock

NCT01602354 is registered in ClinicalTrials.gov with Azienda Ospedaliero, Universitaria Pisana as lead sponsor.

NCT NCT01602354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01602354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endotoxin Activity Assay as a Prognostic Factor in Gram-negative Septic Shock
Lead sponsor
Azienda Ospedaliero, Universitaria Pisana
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2012
Completion date
July 31, 2013
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gram negative septic shock